Eastern Shore Medical Weight Loss
Eastern Shore Medical Weight Loss · 28588 U.S. 98 · Daphne, AL 36526
5.0· 7 Google reviews
Listing updated October 2, 2026
No current plans confirmed — RetaMaps has not yet confirmed this practice's intentions regarding retatrutide. Inclusion on RetaMaps does not mean the provider offers or will offer retatrutide.
Care described on the practice's website
- Medically supervised weight loss
About this practice
Eastern Shore Medical Weight Loss is a medical weight-loss practice in Daphne, Alabama, whose website carries the line Trusted Since 2008. The site describes FDA-approved diet medications and diet plans priced to fit different budgets, and notes that the practice makes no promise about the effectiveness of the medications it prescribes. On Google it holds a 5.0-star rating across 7 reviews dating back to 2012, with 1 in the past year, so review history is limited. The site doesn't name specific GLP-1 medications, so ask which weight-management options it currently offers.
Services & access
| Advertises semaglutide today | Not listed |
| Advertises tirzepatide today | Not listed |
| Telehealth visits | Not listed |
| Cash pay accepted | — |
| Accepts insurance — per practice website | Yes |
| Accepting new patients — per practice website | Yes |
"Not listed" means we didn't find this stated on the practice's public pages — it doesn't mean no. — means unknown. Medication rows describe currently FDA-approved GLP-1 medications the practice advertises today, not retatrutide. Confirm details directly with the practice.
Review activity
Counts computed by RetaMaps from public Google reviews; most recent review 2025-10-26. Read the reviews themselves on the practice's Google listing.
What patients say
Rated ★5.0 across 7 Google reviews. Of the 7 reviews we analyzed, 7 (100%) are positive (4–5★) and 0 (0%) are negative (1–2★).
Most recent Google reviews
Ramona B.★★★★★2025-10-26About to go back. I got so busy , I had went from 228 back to 180. Due to knee pain and surgery put weight back on. On my way back
Michelle H.★★★★★2023-11-28I loved this place, and lost weight with the help of them. Very kind and just wonderful to work with.. only reason I stopped going was because my schedule got hectic and so did life ... if you want an extra boost to help give you that push and want to I recommend them highly ... they really are so caring there.
Rachel L.★★★★★2021-10-29I felt very welcome and comfortable. Ken was great at explaining everything and the whole process was super fast. Would definitely recommend to anyone that's looking to lose weight!
Eric J.★★★★★2021-04-30Top notch service and customer care is given at this facility. Highly recommend to anyone who is thinking about losing weight.
Analysis by RetaMaps of reviews on this practice's public Google Business listing; review themes are detected automatically and reviews reflect their authors' opinions. See all reviews on Google.
Retatrutide is Eli Lilly's investigational once-weekly triple agonist (GIP, GLP-1 and glucagon receptors). Five Phase 3 trials have reported positive results, and Lilly plans to submit it to the FDA in Q1 2027. It is not FDA-approved, has no brand name or price, and cannot be prescribed outside clinical trials or Lilly's physician-requested expanded access program. Products sold online as "research" or compounded retatrutide are not legitimate retatrutide.
- Development
- Phase 3 complete
- FDA status
- Submission planned — Q1 2027 (Lilly guidance)
- Availability
- Not commercially available
- Access routes
- Clinical trials, or Lilly's expanded access program (physician must apply)
Next milestone: TRIUMPH-5 head-to-head vs tirzepatide results (Expected ~Dec 2026)
Sources: Lilly — What to know about retatrutide · Lilly — TRIUMPH-2/TRIUMPH-3 results · BioPharma Dive — FDA submission plans · STAT — Lilly expanded access (Aug 3, 2026) · FDA — Concerns with unapproved GLP-1 drugs